Hematopoietic Cell Transplants
Concepts, Controversies and Future Directions
Herausgeber: Lazarus, Hillard M; Atkinson, Kerry; Munker, Reinhold; Bacigalupo, Andrea; Keating, Armand; Gale, Robert Peter
Hematopoietic Cell Transplants
Concepts, Controversies and Future Directions
Herausgeber: Lazarus, Hillard M; Atkinson, Kerry; Munker, Reinhold; Bacigalupo, Andrea; Keating, Armand; Gale, Robert Peter
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
A practical guide to the most up-to-date and evidence-based approaches in hematopoietic cell transplantation.
Andere Kunden interessierten sich auch für
- Progress in Haematology: Volume 253,99 €
- Managing Myeloproliferative Neoplasms103,99 €
- Anemia Paperback with Online Resource101,99 €
- Carol Marriam MulumbaI Am a Sickle Cell Survivor: Ten Years and Still Counting19,99 €
- W David HardyFundamentals of HIV Medicine 2021211,99 €
- Atta Ur RahmanFrontiers in Clinical Drug Research - Anti-Cancer Agents Volume 6102,99 €
- Ugo TestaProteins of Iron Metabolism90,99 €
-
-
-
A practical guide to the most up-to-date and evidence-based approaches in hematopoietic cell transplantation.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 736
- Erscheinungstermin: 17. Juli 2017
- Englisch
- Abmessung: 287mm x 222mm x 38mm
- Gewicht: 2291g
- ISBN-13: 9781316606698
- ISBN-10: 1316606694
- Artikelnr.: 44971241
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Cambridge University Press
- Seitenzahl: 736
- Erscheinungstermin: 17. Juli 2017
- Englisch
- Abmessung: 287mm x 222mm x 38mm
- Gewicht: 2291g
- ISBN-13: 9781316606698
- ISBN-10: 1316606694
- Artikelnr.: 44971241
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Part I. Recipient Selection for Hematopoietic Cell Transplantation
Part II. Donor Selection for Allogeneic Hematopoietic Cell Transplants
Part III. Collecting and Processing of the Graft
Part IV. Early Posttransplant Interval
Part V. Infections after Hematopoietic Cell Transplantation - Progress?
Part VI. Late Complications of Hematopoietic Cell Transplantation
Part VII. Other Complications of Hematopoietic Cell Transplants
Part VIII. Prevention, Detection and Treatment of Relapse after Hematopoietic Cell Transplants
Part IX. Selection of Conditioning Regimen and Challenges with Different Types of T-Cell Depletion Methods
Part X. Hematopoietic Cell Transplants for Acute Leukemia and Myelodysplastic Syndrome
Part XI. Hematopoietic Cell Transplants for Myeloproliferative Neoplasms
Part XII. Hematopoietic Cell Transplants for Lymphomas - Changing Indications
Part XIII. Plasma Cell Dyscrasias
Part XIV. Autotransplants for Solid Neoplasms
Part XV. Hematopoietic Cell Transplants for Non-Neoplastic Diseases
Part XVI. Novel Transplant Strategies
Part XVII. Novel Cell Therapies and Manipulations.
Part II. Donor Selection for Allogeneic Hematopoietic Cell Transplants
Part III. Collecting and Processing of the Graft
Part IV. Early Posttransplant Interval
Part V. Infections after Hematopoietic Cell Transplantation - Progress?
Part VI. Late Complications of Hematopoietic Cell Transplantation
Part VII. Other Complications of Hematopoietic Cell Transplants
Part VIII. Prevention, Detection and Treatment of Relapse after Hematopoietic Cell Transplants
Part IX. Selection of Conditioning Regimen and Challenges with Different Types of T-Cell Depletion Methods
Part X. Hematopoietic Cell Transplants for Acute Leukemia and Myelodysplastic Syndrome
Part XI. Hematopoietic Cell Transplants for Myeloproliferative Neoplasms
Part XII. Hematopoietic Cell Transplants for Lymphomas - Changing Indications
Part XIII. Plasma Cell Dyscrasias
Part XIV. Autotransplants for Solid Neoplasms
Part XV. Hematopoietic Cell Transplants for Non-Neoplastic Diseases
Part XVI. Novel Transplant Strategies
Part XVII. Novel Cell Therapies and Manipulations.
Part I. Recipient Selection for Hematopoietic Cell Transplantation
Part II. Donor Selection for Allogeneic Hematopoietic Cell Transplants
Part III. Collecting and Processing of the Graft
Part IV. Early Posttransplant Interval
Part V. Infections after Hematopoietic Cell Transplantation - Progress?
Part VI. Late Complications of Hematopoietic Cell Transplantation
Part VII. Other Complications of Hematopoietic Cell Transplants
Part VIII. Prevention, Detection and Treatment of Relapse after Hematopoietic Cell Transplants
Part IX. Selection of Conditioning Regimen and Challenges with Different Types of T-Cell Depletion Methods
Part X. Hematopoietic Cell Transplants for Acute Leukemia and Myelodysplastic Syndrome
Part XI. Hematopoietic Cell Transplants for Myeloproliferative Neoplasms
Part XII. Hematopoietic Cell Transplants for Lymphomas - Changing Indications
Part XIII. Plasma Cell Dyscrasias
Part XIV. Autotransplants for Solid Neoplasms
Part XV. Hematopoietic Cell Transplants for Non-Neoplastic Diseases
Part XVI. Novel Transplant Strategies
Part XVII. Novel Cell Therapies and Manipulations.
Part II. Donor Selection for Allogeneic Hematopoietic Cell Transplants
Part III. Collecting and Processing of the Graft
Part IV. Early Posttransplant Interval
Part V. Infections after Hematopoietic Cell Transplantation - Progress?
Part VI. Late Complications of Hematopoietic Cell Transplantation
Part VII. Other Complications of Hematopoietic Cell Transplants
Part VIII. Prevention, Detection and Treatment of Relapse after Hematopoietic Cell Transplants
Part IX. Selection of Conditioning Regimen and Challenges with Different Types of T-Cell Depletion Methods
Part X. Hematopoietic Cell Transplants for Acute Leukemia and Myelodysplastic Syndrome
Part XI. Hematopoietic Cell Transplants for Myeloproliferative Neoplasms
Part XII. Hematopoietic Cell Transplants for Lymphomas - Changing Indications
Part XIII. Plasma Cell Dyscrasias
Part XIV. Autotransplants for Solid Neoplasms
Part XV. Hematopoietic Cell Transplants for Non-Neoplastic Diseases
Part XVI. Novel Transplant Strategies
Part XVII. Novel Cell Therapies and Manipulations.